Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Chemomab Therapeutics Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +1 vs. Q4 2025
- Shares held
- 351.6K
- −15.8K (−4.3%) vs. Q4 2025
- Total value
- $551.9K
- −$54.2K (−8.9%) vs. Q4 2025
- New holders
- 4
- 6 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $615.3K |
| Q1 2026 | 15 | $551.9K |
| Q4 2025 | 14 | $606.1K |
| Q3 2025 | 10 | $1.03M |
| Q2 2025 | 14 | $4.91M |
| Q1 2025 | 17 | $4.07M |
| Q4 2024 | 16 | $7.53M |
| Q3 2024 | 15 | $7.14M |
| Q2 2024 | 15 | $2.44M |
| Q1 2024 | 14 | $2.07M |
| Q4 2023 | 16 | $1.43M |
| Q3 2023 | 11 | $2.26M |
| Q2 2023 | 11 | $3.33M |
| Q1 2023 | 13 | $4.56M |
| Q4 2022 | 14 | $10.6M |
| Q3 2022 | 15 | $8.09M |
| Q2 2022 | 13 | $12.2M |
| Q1 2022 | 15 | $15.9M |
| Q4 2021 | 14 | $22.7M |
| Q3 2021 | 15 | $35.9M |
| Q2 2021 | 12 | $58.7M |
| Q1 2021 | 10 | $82.6M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Chemomab Therapeutics Ltd.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 80,000 | $125.6K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 64,182 | $100.8K | 0.00% | −39,599−38.2% | Reduced |
| Kestra Private Wealth Services, LLC | 61,710 | $96.9K | 0.00% | +10,000+19.3% | Added |
| Ikarian Capital, LLC | 51,793 | $81.3K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 18,629 | $29.2K | 0.00% | −384−2.0% | Reduced |
| Rhumbline Advisers | 18,366 | $28.8K | 0.00% | +510+2.9% | Added |
| SmartHarvest Portfolios, LLC | 14,566 | $22.9K | 0.01% | +14,566 | New |
| Susquehanna International Group, LLP | 13,491 | $21.2K | 0.00% | +13,491 | New |
| BNP Paribas Arbitrage, SA | 8,425 | $13.2K | 0.00% | +300+3.7% | Added |
| Philadelphia Investment Partners, LLC | 8,200 | $12.9K | 0.01% | +8,200 | New |
| GAMMA Investing LLC | 7,579 | $11.9K | 0.00% | +5,065+201.5% | Added |
| Morgan Stanley | 4,575 | $7.18K | 0.00% | +800+21.2% | Added |
| SBI Securities Co., Ltd. | 28 | $44 | 0.00% | +2+7.7% | Added |
| UBS Group AG | 8 | $13 | 0.00% | −2,245−99.6% | Reduced |
| Caitong International Asset Management Co., Ltd | 8 | $13 | 0.00% | +8 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,598−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,933−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |